Feltes, T F <br/><br/>
Palivizumab prophylaxis in haemodynamically significant congenital heart disease.  [electronic resource] 

 -  Archives of disease in childhood  Aug 2005 
 - 875-7; author reply 875-7 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>1468-2044 
<br/><br/><label>Standard No.: </label>10.1136/adc.2004.069948  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antiviral Agents--therapeutic use<br/>Child, Preschool<br/>Data Interpretation, Statistical<br/>Heart Defects, Congenital--complications<br/>Hospitalization<br/>Humans<br/>Infant<br/>Palivizumab<br/>Virus Diseases--prevention & control